Sabra Health Care REIT, Inc. (SBRA) on Thursday updated its 2013 guidance to take into account the issuance of $200 million of 2023 Notes, redemption of $113.8 million of the 2018 Notes and investments through March 31, 2013 of $17.5 million.
In addition, the updated 2013 guidance no longer contemplates an issuance of $75.0 to $100.0 million of equity securities in 2013.
For fiscal 2013, the company now expects FFO to range between $1.53 and $1.57 per share and Normalized FFO, after adjusting for the redemption premium, write-off of deferred financing costs and issuance premiums associated with the redemption of $113.8 million of the 2018 Notes, to range between $1.79 and $1.83 per common share.
The company expects AFFO for fiscal 2013 to range between $1.42 and $1.46 per share and Normalized AFFO, after adjusting for the redemption premium, to range between $1.66 and $1.70 per share.
The company also said it now expects net income attributable to common stockholders for fiscal 2013 to range between $0.65 and $0.69 per share.
Analysts polled by Thomson Reuters currently expect the company to report FFO of $1.88 per share for the full year 2013. Analysts' estimates typically exclude special items.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.